Dr. Pasi Janne is the director of three cancer programs at Dana-Farber Cancer Institute in addition to serving as a professor of medicine at Harvard Medical School.

Janne directs the Lowe Center for Thoracic Oncology, Belfer Center for Applied Cancer Science and Chen-Huang Center for EGFR Mutant Lung Cancers. He also serves a leadership role at the Janne Lab, which is located at the Longwood Center in Boston.

His main research interest is the study of epidermal growth factor receptor mutations, which play a role in the development of cancers such as mesothelioma and lung cancer.

He is also interested in developing innovative approaches to mesothelioma treatment, including photodynamic therapy, immunotherapy, heated chemotherapy and gene therapy. He and his colleagues are testing a variety of molecular therapeutic targets in hopes of developing new and novel treatments for all forms of malignant mesothelioma.

Janne received his M.D. and Ph.D. from the Perelman School of Medicine at the University of Pennsylvania in 1996. He completed his residency in internal medicine at Brigham and Women’s Hospital in 1998, and a fellowship in hematology and oncology at Dana-Farber/Partners CancerCare in 2001. In 2002, he earned a master’s degree in clinical investigation from Harvard University.